New Delhi, April 11: AstraZeneca Pharma has fixed the floor price at Rs 854.1 apiece for delisting its shares. AstraZeneca Pharmaceuticals AB, Sweden, holds 75 per cent in AstraZeneca Pharma India. AstraZeneca said the increase in promoter’s ownership would provide greater operational flexibility to support the business.
Mumbai, April 11: The SBI has mopped up $1.25 billion in overseas debt sale through a dual tranche bond programme, making it the largest offering from a domestic issuer. The bank raised $750 million in 5-year money at US treasury interest rate plus 205 basis points, while it priced the 10-year $500 million issue at 225 basis points over the treasury.
New Delhi, April 11: The railways’ earnings rose to Rs 1,40,485.02 crore in 2013-14 from Rs 1,21,831.65 crore last fiscal. The railways carried 1053.54 million tonnes of freight in 2013-14, an increase of 43.68mt over the year-ago period.
New Delhi, April 11: Sun Pharma will make an open offer worth Rs 18.4 crore to acquire a little over 28 per cent stake in Zenotech Laboratories, in which Ranbaxy holds a significant stake.
